Literature DB >> 12889525

Thymoquinone-induced relaxation of guinea-pig isolated trachea.

A A Al-Majed1, M H Daba, Y A Asiri, O A Al-Shabanah, A A Mostafa, H A El-Kashef.   

Abstract

The effect of thymoquinone (TQ), the main constituent of the volatile oil of black seed (Nigella sativa), on the guinea-pig isolated tracheal zig-zag preparation was investigated. TQ caused a concentration-dependent decrease in the tension of the tracheal smooth muscle precontracted by carbachol. The effects of TQ were significantly potentiated by pretreatment of the tracheal preparations with quinacrine, a phospholipase A2 inhibitor, nordihydroguiaretic acid, a lipoxygenase inhibitor and by pretreatment with methylene blue, an inhibitor of soluble guanylyl cyclase. On the other hand, the effects of TQ were not influenced by pretreatment of the tracheal preparations with indomethacin, a cyclooxygenase inhibitor, propranolol, a non-selective beta-adrenoceptor blocker or by the pretreatment with theophylline, an adenosine receptors antagonist TQ totally abolished the pressor effects of histamine and serotonin on the guinea-pig isolated tracheal and ileum smooth muscles. The results of the present study suggest that TQ induced relaxation of precontracted tracheal preparation is probably mediated, at least in part, by inhibition of lipoxygenase products of arachidonic acid metabolism and possibly by non-selective blocking of the histamine and serotonin receptors. This relaxant effect of TQ, further support the traditional use of black seeds either alone or in combination with honey to treat bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12889525

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  9 in total

1.  Unconventional therapy use among asthma patients in a tertiary care center in Riyadh, Saudi Arabia.

Authors:  Mohamed S Al Moamary
Journal:  Ann Thorac Med       Date:  2008-04       Impact factor: 2.219

2.  Nigella sativa L. seed extract modulates the neurotransmitter amino acids release in cultured neurons in vitro.

Authors:  Tarek El-Naggar; María Pilar Gómez-Serranillos; Olga María Palomino; Carmen Arce; María Emilia Carretero
Journal:  J Biomed Biotechnol       Date:  2010-06-16

Review 3.  The relaxant effect of Nigella sativa on smooth muscles, its possible mechanisms and clinical applications.

Authors:  Rana Keyhanmanesh; Zahra Gholamnezhad; Mohammad Hossien Boskabady
Journal:  Iran J Basic Med Sci       Date:  2014-12       Impact factor: 2.699

Review 4.  Clinical and experimental effects of Nigella sativa and its constituents on respiratory and allergic disorders.

Authors:  Zahra Gholamnezhad; Farzaneh Shakeri; Saeideh Saadat; Vahideh Ghorani; Mohammad Hossein Boskabady
Journal:  Avicenna J Phytomed       Date:  2019 May-Jun

5.  Intestinal, airway, and cardiovascular relaxant activities of thymoquinone.

Authors:  Muhammad Nabeel Ghayur; Anwarul Hassan Gilani; Luke Jeffrey Janssen
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-18       Impact factor: 2.629

Review 6.  Chemical composition of Nigella sativa Linn: Part 2 Recent advances.

Authors:  M Akram Khan; M Afzal
Journal:  Inflammopharmacology       Date:  2016-04-11       Impact factor: 4.473

7.  Panacea seed "Nigella": A review focusing on regenerative effects for gastric ailments.

Authors:  Shahida A Khan; Aziz M Khan; Sajjad Karim; Mohammad Amjad Kamal; Ghazi A Damanhouri; Zeenat Mirza
Journal:  Saudi J Biol Sci       Date:  2014-10-13       Impact factor: 4.219

Review 8.  Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin.

Authors:  Sameer N Goyal; Chaitali P Prajapati; Prashant R Gore; Chandragouda R Patil; Umesh B Mahajan; Charu Sharma; Sandhya P Talla; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2017-09-21       Impact factor: 5.810

Review 9.  Medicinal benefits of Nigella sativa in bronchial asthma: A literature review.

Authors:  Abdulrahman Koshak; Emad Koshak; Michael Heinrich
Journal:  Saudi Pharm J       Date:  2017-07-11       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.